Over the holidays, Drunk Elephant skincare was a wish list mainstay, sending confused parents to beauty stores to puzzle over why their middle schoolers needed so many expensive products.
Jan 15, 2024
0
0
Chronic pain affects approximately 60% of people living with traumatic brain injury (TBI), even up to 30 years after injury, according to new research published in the Journal of Head Trauma Rehabilitation.
Jan 3, 2024
0
0
Despite the effectiveness of the newer generation of anti-obesity drugs—called GLP-1 receptor agonists—few can tolerate them in the long run. A new study, published in the journal Obesity, reveals that of people prescribed ...
Dec 24, 2023
0
1
Treatment with bendamustine prior to CAR T-cell therapy in patients with refractory large B-cell lymphoma associates with poorer treatment outcomes, finds a recent study.
Dec 19, 2023
0
1
Patients undergoing total thyroidectomy typically require lifelong oral levothyroxine sodium (L-T4) treatment. While effective in maintaining basic serum hormone levels, this treatment falls short in restoring the dynamic, ...
Dec 12, 2023
0
33
The treatment landscape for acute myeloid leukemia (AML) is evolving rapidly, as research discoveries at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine and other academic cancer ...
Dec 11, 2023
0
0
As syphilis cases surge across America, a group representing the nation's STD specialists says members are reporting shortages of a drug essential to fighting the disease.
Dec 4, 2023
0
0
Botulinum toxin-A (BTX), also known as Botox, is used to treat a range of neuromuscular disorders, including muscle spasms, dystonia, eye twitching, overactive bladder, and spasticity associated with cerebral palsy or stroke. ...
Nov 17, 2023
0
2
In a paper published in Nature Mental Health, Northeastern psychology professor Susan Whitfield-Gabrieli advises policy makers to consider turning to the low-cost, readily available practice of mindfulness meditation to change ...
Nov 14, 2023
0
13
Findings from a Phase I trial reported by a Cleveland Clinic physician show that a single dose of an experimental therapy produced greater than 94% reductions in blood levels of lipoprotein(a), a key driver of heart disease ...
Nov 13, 2023
0
96
